Best Project Manufacturing: Rentschler Biopharma Manufacturing Center (RBMC)
Featuring a 45,000-sq-ft, two-level building expansion with a 10,000-sq-ft retrofit of existing space, this project more than doubles Rentschler Biopharma’s commercial cGMP biopharmaceutical manufacturing capacity aimed at treating multiple diseases, such as cancer and COVID-19.
Completed in 20 months in March 2023, the new facility supports “fed batch” production, an operational technique where nutrients are supplied to a bioreactor during cultivation of up to two products at the 2000 L scale, with 22,000 sq ft of manufacturing clean room space, a cell culture room and support areas for four 2000 L single-use bioreactors.